Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL870314 | 0.84 | SMN1; SMN2 (0.46) | TSHRSMN1; SMN2LMNAALDH1A1HSD17B10 | |
| SCHEMBL31443013 | 0.83 | TSHR (0.33) | TSHR | |
| N-Ethyl-N-(2-Hydroxyethyl)Nitrosamine SCHEMBL6304339 | 0.83 | — | — | |
| SCHEMBL4562415 | 0.81 | TSHR (0.57) | TSHR | |
| SCHEMBL3341604 | 0.78 | — | — | |
| SCHEMBL15630544 | 0.77 | ALDH1A1 (0.43) | TSHRSMN1; SMN2LMNAALDH1A1HSD17B10 | |
| SCHEMBL10883185 | 0.77 | TSHR (0.75) | TSHRALDH1A1 | |
| SCHEMBL19063242 | 0.74 | — | — | |
| SCHEMBL4732004 | 0.73 | CA12 (0.40) | TSHRSMN1; SMN2LMNAALDH1A1HSD17B10 | |
| SCHEMBL11525062 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024220366-A1 | VAN DER WAALS MOIRÉ HOMOBILAYER FOR GATE-TUNABLE FRACTIONAL QUANTUM ANOMALOUS HALL STATE | UNIVERSITY OF WASHINGTON (US) | 2024-10-24 | — | — | WO | disclosed |
| CN-118355044-A | Active energy ray-curable resin composition, cured product, laminate, and article | DIC株式会社 | 2024-07-16 | — | — | CN | disclosed |
| CN-118255955-A | Resin, curable resin composition, cured product, resin material for solder resist, insulating material, and resist member | DIC株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-117687141-B | Phase difference film, polymerizable composition, and method for producing phase difference film | 成都瑞波科材料科技有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-114531881-B | Acid group-containing (meth) acrylate resin and composition thereof | DIC株式会社 | 2024-05-10 | — | — | CN | disclosed |
| CN-116444732-B | Polymerizable composition, phase difference film, preparation method and display device | 成都瑞波科材料科技有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117700734-A | Imide resin, curable resin composition, and cured product | DIC株式会社 | 2024-03-15 | — | — | CN | disclosed |
| CN-117687141-A | Phase difference film, polymerizable composition, and method for producing phase difference film | 成都瑞波科材料科技有限公司 | 2024-03-12 | — | — | CN | disclosed |
| WO-2023018893-A9 | OPTICALLY CONTROLLABLE MESOSCOPIC SPIN ORDER IN SEMICONDUCTORS | THE UNIVERSITY OF CHICAGO (US) | 2024-02-22 | — | — | WO | disclosed |
| CN-117568049-A | Liquid crystal composition, phase difference film, preparation method and display device | 成都瑞波科材料科技有限公司 | 2024-02-20 | — | — | CN | disclosed |
| US-20140235894-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-8748659-B2 | Method for producing alpha,beta-unsaturated carboxylic acid-N,N-disubstituted amide and method for producing 3-alkoxycarboxylic acid-N,N-disubstituted amide | IDEMITSU KOSAN CO., LTD. (JP) | 2014-06-10 | — | — | US | disclosed |
| WO-2014045783-A1 | ORIGINAL PLANOGRAPHIC PRINTING PLATE, AND PLATE MAKING METHOD | 富士フイルム株式会社 (JP) | 2014-03-27 | — | — | WO | disclosed |
| US-20130309411-A1 | BIREFRINGENT LENS MATERIAL FOR STEREOSCOPIC IMAGE DISPLAY DEVICE AND METHOD FOR PRODUCING BIREFRINGENT LENS FOR STEREOSCOPIC IMAGE DISPLAY DEVICE | DIC CORPORATION (JP) | 2013-11-21 | — | — | US | disclosed |
| EP-2664611-A1 | Method for producing alpha,beta-unsaturated carboxylic acid-N,N-disubstituted amide and method for producing 3-alkoxycarboxylic acid-N,N-disubstituted amide | Idemitsu Kosan Co., Ltd (JP) | 2013-11-20 | — | — | EP | disclosed |
| EP-2664610-A1 | Method for producing alpha,beta-unsaturated carboxylic acid-N,N-disubstituted amide and method for producing 3-alkoxycarboxylic acid-N,N-disubstituted amide | Idemitsu Kosan Co., Ltd (JP) | 2013-11-20 | — | — | EP | disclosed |
| EP-2660631-A1 | BIREFRINGENT LENS MATERIAL FOR STEREOSCOPIC IMAGE DISPLAY DEVICE, AND METHOD OF MANUFACTURING BIREFRINGENT LENS FOR STEREOSCOPIC IMAGE DISPLAY DEVICE | DIC Corporation (JP) | 2013-11-06 | — | — | EP | disclosed |
| CN-103282800-A | Birefringent lens material for stereoscopic image display device and method for manufacturing birefringent lens for stereoscopic image display device | DAINIPPON INK & CHEMICALS | 2013-09-04 | — | — | CN | disclosed |
| US-20120088931-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| EP-2426103-A1 | METHOD FOR PRODUCING ALPHA, BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | Idemitsu Kosan Co., Ltd. (JP) | 2012-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140235894-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | FASN, NAAA, FAAH | TSHR 4479/4885SMN1; SMN2 3053/4885LMNA 368/4885 |
| US-20120088931-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | FASN, NAAA, FAAH | TSHR 4479/4885SMN1; SMN2 3053/4885LMNA 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.